Current Ratio of Taysha Gene Therapies, Inc. from 30 Jun 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Taysha Gene Therapies, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2021 to 30 Sep 2025.
  • Taysha Gene Therapies, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 855%, a 91% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Taysha Gene Therapies, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 855% +409% +91% 30 Sep 2025
Q2 2025 716% +498% +229% 30 Jun 2025
Q1 2025 537% +372% +225% 31 Mar 2025
Q4 2024 477% +338% +243% 31 Dec 2024
Q3 2024 447% +333% +294% 30 Sep 2024
Q2 2024 217% +85% +64% 30 Jun 2024
Q1 2024 165% +16% +11% 31 Mar 2024
Q4 2023 139% -33% -19% 31 Dec 2023
Q3 2023 113% -106% -48% 30 Sep 2023
Q2 2023 132% -158% -54% 30 Jun 2023
Q1 2023 149% -241% -62% 31 Mar 2023
Q4 2022 172% -392% -69% 31 Dec 2022
Q3 2022 219% -704% -76% 30 Sep 2022
Q2 2022 290% -1199% -81% 30 Jun 2022
Q1 2022 390% 31 Mar 2022
Q4 2021 565% 31 Dec 2021
Q3 2021 923% 30 Sep 2021
Q2 2021 1489% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.